0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
**IMPORTANT**
The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Canadian Hemochromatosis Society
a/k/a: CHS
Address
7000 Minoru Boulevard Suite 285
Richmond
British Columbia, V6Y 3Z5
Canada
Phone
604-279-7135
Fax
604-279-7138
800 Number
877-223-4766
TDD
--
Email Address
office@toomuchiron.ca
Chapters
41
Website
The Canadian Hemochromatosis Society (CHS) is a non-profit support organization dedicated to providing information and support to individuals and families affected by hereditary hemochromatosis. This is a metabolic disorder characterized by excessive absorption of iron. Without appropriate treatment, excess iron may accumulate in the liver, heart, pancreas, and other organs, resulting in possible multiple organ dysfunction and tissue damage. Established in 1982, the society is committed to increasing awareness among the Canadian public and the medical community about the importance of early screening for, and diagnosis of, hemochromatosis. The society maintains a central registry of all reported cases of hereditary hemochromatosis and provides information regarding appropriate screening and diagnostic testing. CHS also publishes a biannual newsletter that is distributed to doctors and interested individuals all over the world. Its membership questionnaire includes specific questions designed to assist researchers.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.
